Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback